Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03797677 · ClinicalTrials.gov registry record · NA
MN4000 for Treatment of CF and MND Patients in the Home Setting
A NA study, sponsored by Hill-Rom.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03797677 is a NA study that has completed, run by Hill-Rom. The registered enrollment target is 10 participants.
The verdict
NCT03797677, a NA study, has completed, sponsored by Hill-Rom.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study was a non-randomized open label pilot study. It was an observational design conducted at one (1) site in the US. All enrolled subjects received treatment with the MN4000. This pilot study evaluated subject satisfaction with the therapy and adherence to the therapy during the 90-day treatment period, and also collected clinical outcome data. Outcomes were assessed before, during and after the MN4000 treatment period.
Interventions
- DEVICE MN 4000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2017-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03797677
The ClinicalTrials.gov registry entry for NCT03797677 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill-Rom, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MN 4000 is the first listed.
NCT03797677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03797677 about?
NCT03797677 is a clinical study titled "MN4000 for Treatment of CF and MND Patients in the Home Setting". The study was a non-randomized open label pilot study. It was an observational design conducted at one (1) site in the US. All enrolled subjects received treatment with the MN4000. This pilot study evaluated subject satisfaction with the therapy and adherence to the therapy during the 90-day treatm...
What is the current status of trial NCT03797677?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-03-09. Estimated completion is 2017-11-30.
What interventions are being tested in trial NCT03797677?
The interventions under investigation include: MN 4000 (DEVICE).
Who is sponsoring clinical trial NCT03797677?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.